← Back to Search

Population-Health Management for COPD (EQuiP COPD Trial)

N/A
Recruiting
Led By David H Au, MD
Research Sponsored by Seattle Institute for Biomedical and Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recent discharge from hospital for COPD exacerbation
Treatment for COPD without evidence of spirometry within 10 years, or no airflow obstruction on existing spirometr
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after intervention
Awards & highlights

EQuiP COPD Trial Summary

This trial will assess whether pharmacist-led management of COPD is as effective as management by pulmonary specialists, to improve quality-of-care & COPD-related quality-of-life.

Who is the study for?
This trial is for patients with COPD who are current smokers not on cessation aid, have had a recent exacerbation or hospital discharge due to COPD, or use inhaled corticosteroids without meeting criteria. Primary care providers at participating sites can also join.Check my eligibility
What is being tested?
The study compares population management of COPD by pharmacists versus pulmonary specialists. Both will review patient cases and provide guideline-based recommendations through E-consults for primary care providers to act upon.See study design
What are the potential side effects?
Since the interventions involve management strategies rather than direct medications, specific side effects are not detailed; however, outcomes like medication adherence and quality-of-life improvements are being measured.

EQuiP COPD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was recently discharged from the hospital for a COPD flare-up.
Select...
I am being treated for COPD but haven't had a lung function test in 10 years or my test shows no blockage.
Select...
I was prescribed an inhaled corticosteroid but shouldn't have been.
Select...
I have COPD, smoke, and am not using help to quit smoking.
Select...
I am being treated for COPD but haven't had a lung function test in 10 years, or my lung function tests show no obstruction.

EQuiP COPD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients with COPD exacerbation, pneumonia, hospitalization, or Death (composite outcome)
Secondary outcome measures
Acceptance of Recommendations
COPD-related quality- of-life
Heterogeneity of treatment effect on primary and by subgroup
+5 more

EQuiP COPD Trial Design

2Treatment groups
Active Control
Group I: Pulmonologist ledActive Control1 Intervention
Pulmonologists will conduct population health management for patients with COPD
Group II: Pharmacist ledActive Control1 Intervention
Pharmacists will conduct population health management for patients with COPD

Find a Location

Who is running the clinical trial?

Seattle Institute for Biomedical and Clinical ResearchLead Sponsor
52 Previous Clinical Trials
9,400 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,992,948 Total Patients Enrolled
David H Au, MDPrincipal InvestigatorVA Puget Sound Health Care System

Media Library

Population-health management Clinical Trial Eligibility Overview. Trial Name: NCT05718102 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Pulmonologist led, Pharmacist led
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Population-health management Highlights & Side Effects. Trial Name: NCT05718102 — N/A
Population-health management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05718102 — N/A
Chronic Obstructive Pulmonary Disease Patient Testimony for trial: Trial Name: NCT05718102 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How widely distributed is the research taking place in this state?

"Patients are being enrolled for this trial at locations such as the Portland VA Medical Center, Ralph H. Johnson VA Medical Center in Charleston, and Seattle's VA Puget Sound Health Care System. Additionally, there are 5 more sites recruiting patients across America."

Answered by AI

Can individuals still join this investigation?

"The information on clinicaltrials.gov indicates that this specific trial is no longer searching for participants; it was initially posted on May 16th 2023 and updated lastly on February 6th 2023. Fortunately, there are currently 245 other medical trials actively recruiting volunteers as an alternative option."

Answered by AI

Who else is applying?

What state do they live in?
Oregon
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+
What site did they apply to?
Minneapolis VA Health Care System

Why did patients apply to this trial?

I am slowly, so far, losing lung capacity (47%) & so I am looking for new meds, even to reverse it.
PatientReceived 1 prior treatment
~2667 spots leftby Jan 2027